Corinne D. Engelman, Ph.D.
Affiliations: | 2006 | University of Colorado Anschutz Medical Campus, Denver, Aurora, CO |
Area:
Public Health, GeneticsGoogle:
"Corinne Engelman"Cross-listing: PHTree
Parents
Sign in to add mentor| Jill M. Norris | grad student | 2006 | University of Colorado, Denver | |
| (Effects of vitamin D genes on measures of insulin secretion, insulin sensitivity and adiposity: An ancillary study to the Insulin Resistance Atherosclerosis Study (IRAS) Family Study.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Martinelli F, Heinken A, Henning AK, et al. (2024) Whole-body metabolic modelling reveals microbiome and genomic interactions on reduced urine formate levels in Alzheimer's disease. Scientific Reports. 14: 6095 |
| Xu Y, Sun Z, Jonaitis E, et al. (2023) Apolipoprotein E moderates the association between non-APOE polygenic risk score for Alzheimer's disease and aging on preclinical cognitive function. Alzheimer's & Dementia : the Journal of the Alzheimer's Association |
| Martinelli F, Heinken A, Henning AK, et al. (2023) Whole-body modelling reveals microbiome and genomic interactions on reduced urine formate levels in Alzheimer's disease. Research Square |
| Dong R, Lu Q, Kang H, et al. (2023) CSF metabolites associated with biomarkers of Alzheimer's disease pathology. Frontiers in Aging Neuroscience. 15: 1214932 |
| Xu Y, Vasiljevic E, Deming YK, et al. (2023) Effect of Pathway-Specific Polygenic Risk Scores for Alzheimer's Disease (AD) on Rate of Change in Cognitive Function and AD-Related Biomarkers Among Asymptomatic Individuals. Journal of Alzheimer's Disease : Jad |
| Xu Y, Sun Z, Jonaitis E, et al. (2023) Apolipoprotein E moderates the association between Non- Polygenic Risk Score for Alzheimer's Disease and Aging on Preclinical Cognitive Function. Medrxiv : the Preprint Server For Health Sciences |
| Wang C, Western D, Yang C, et al. (2023) Unique genetic architecture of CSF and brain metabolites pinpoints the novel targets for the traits of human wellness. Research Square |
| Panyard DJ, McKetney J, Deming YK, et al. (2023) Large-scale proteome and metabolome analysis of CSF implicates altered glucose and carbon metabolism and succinylcarnitine in Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association |
| Pettigrew C, Nazarovs J, Soldan A, et al. (2023) Alzheimer's disease genetic risk and cognitive reserve in relationship to long-term cognitive trajectories among cognitively normal individuals. Alzheimer's Research & Therapy. 15: 66 |
| Dong R, Denier-Fields DN, Van Hulle CA, et al. (2023) Identification of plasma metabolites associated with modifiable risk factors and endophenotypes reflecting Alzheimer's disease pathology. European Journal of Epidemiology |